GleamWall
中文EN

PAHC PHIBRO ANIMAL HEALTH CORP

Pharmaceutical Preparations · Nasdaq · SEC CIK 1069899 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.1%
TTM net income YoY51.5%
TTM EPS YoY49.7%
Revenue 3-yr CAGR16.4%
Net income 3-yr CAGR70.5%

Margins

Gross margin33.8%
Operating margin12.5%
Net margin6.7%
FCF margin1.4%
EBITDA margin15.9%

Returns

ROE28.2%
ROA7.1%
ROIC (approx.)15.6%
Asset turnover1.06x

Leverage & solvency

Liabilities / assets72.4%
Debt / equity1.46x
Current ratio3.20x
Interest coverage4.18x

Cash quality & payout

Operating cash flow / net income0.83x
Accruals ratio1.2%
Payout ratio19.0%
Capex / revenue4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q4*2026-06-302026Q32026-03-312026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-31
Income statement
Revenue$386.77M$396.75M$383.54M$373.91M$363.89M$378.70M$347.82M$309.26M
Cost of revenue$258.24M$262.35M$257.87M$241.25M$244.11M$268.69M$243.26M$207.39M
Gross profit$128.54M$134.40M$125.67M$132.66M$119.78M$110.01M$104.57M$101.87M
SG&A expense$78.90M$86.24M$81.02M$82.33M$68.52M$76.29M$71.05M$76.34M
Operating income$49.64M$48.16M$44.65M$50.33M$51.26M$33.72M$33.52M$25.53M
Interest expense$12.25M$10.71M$10.68M$12.48M$12.54M$9.03M$9.65M$9.78M
Pretax income$38.78M$32.34M$32.31M$36.42M$36.27M$23.85M$29.69M$4.84M
Income tax$9.26M$10.63M$8.29M$8.97M$9.74M$6.62M$8.81M$1.65M
Net income$29.52M$21.71M$24.02M$27.46M$26.53M$17.22M$20.88M$3.19M
EBITDA$63.22M$61.50M$57.10M$63.22M$64.09M$46.13M$46.13M$37.11M
EPS (basic)0.73—0.590.680.65—0.520.08
EPS (diluted)0.72—0.590.670.65—0.510.08
Dividends declared per share0.120.120.120.120.120.120.120.12
Weighted avg. shares (diluted)40.96M—41.04M40.96M40.88M—40.71M40.72M
Balance sheet
Cash & equivalents$75.55M$61.42M$54.93M$55.49M$72.77M$68.04M$60.35M$67.07M
Short-term investments$7.58M$20.57M$22.52M$19.02M$12.50M$9.00M$10.00M$0
Receivables$221.71M$238.79M$221.55M$215.87M$217.90M$227.98M$197.52M$191.79M
Inventory$567.14M$534.88M$539.70M$517.35M$471.77M$444.43M$448.39M$427.22M
Current assets$945.17M$935.51M$894.07M$862.18M$835.80M$810.61M$776.02M$746.15M
PP&E, net$372.73M$369.17M$359.27M$355.38M$354.78M$354.69M$336.09M$337.66M
Goodwill$60.03M$60.05M$59.89M$59.81M$59.71M$59.65M$54.57M$54.55M
Intangibles$28.30M$30.05M$31.68M$33.07M$34.96M$36.47M$37.77M$39.89M
Total assets$1.51B$1.50B$1.45B$1.41B$1.39B$1.36B$1.32B$1.29B
Current liabilities$295.79M$316.47M$281.87M$282.37M$270.14M$293.47M$266.48M$233.25M
Short-term debt$25.02M$25.02M$22.83M$20.64M$18.44M$16.25M$16.25M$16.25M
Long-term debt$585.85M$591.77M$597.68M$603.60M$609.52M$615.43M$619.16M$622.88M
Total debt$610.88M$616.79M$620.52M$624.24M$627.96M$631.68M$635.41M$639.13M
Total liabilities$1.10B$1.12B$1.08B$1.07B$1.07B$1.08B$1.05B$1.04B
Shareholders' equity$417.67M$385.48M$361.83M$332.36M$311.68M$285.68M$265.99M$246.80M
Net debt$535.33M$555.38M$565.59M$568.75M$555.19M$563.65M$575.05M$572.06M
Cash flow statement
Operating cash flow$26.08M$24.09M$16.21M$19.35M$9.30M$21.27M$43.15M$3.08M
Capital expenditure$18.78M$18.87M$15.32M$11.10M$13.81M$13.14M$7.75M$7.82M
Free cash flow$7.30M$5.22M$890,000$8.26M-$4.50M$8.13M$35.41M-$4.75M
Investing cash flow-$5.95M-$16.45M-$16.81M-$17.18M-$21.01M-$7.03M-$18.25M-$260.47M
Financing cash flow-$5.63M-$1.61M-$2.30M-$18.98M$16.34M-$7.77M-$32.22M$276.32M
Depreciation & amortization$13.58M$13.35M$12.45M$12.89M$12.83M$12.41M$12.62M$11.57M
Stock-based compensation$804,000$413,000$411,000$434,000$339,000$179,000$179,000$180,000
Dividends paid$4.87M$4.87M$4.87M$4.86M$4.86M$4.86M$4.87M$4.86M

Free plan shows the latest 8 periods; Pro shows all 57 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.